Date post: | 06-Apr-2018 |
Category: |
Documents |
Upload: | elaine-gonzales-casin |
View: | 220 times |
Download: | 0 times |
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 1/72
Bronchial
Asthma
Casin, Elaine Gonzales Dr. CantimbuhanSenior Intern Moderator
27 Januar 2012
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 2/72
GENERAL OBJECTIVES:-To present a patient with Bronchial Asthma-DifferentialDiagnosis for Bronchial Asthma-To diagnose patients with Bronchial Asthma- Management for patients with BronchialAsthma
SPECIFIC OBJECTIVES:-To present a clinical history & PE of patients withbronchial asthma in exacerbation-To present the Classifications by asthma severity and
asthma control used to diagnose patients with BronchialAsthma-To present the Specific Management (pharmacologic andControl-Avoidance)
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 3/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENT
G
E
NE
R
AL
DA
T
A
D.D
-8 y/o, female
-Buddhist
-Filipino- Born and is currently residing in
Dasmarinas, Cavite
- Admitted: January 04, 2012, 4pm
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 4/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENT
C
H
IE
F
CO
M
P
LA
I
N
T
³Difficulty of Breathing´
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 5/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENTHx
OF
P
R
E
S
EN
T
I
LL
N
E
S
S
3 days PTA
- (+) productive cough,
whitish phlegm, worse
at night
- (-) colds, fever, headache,dysphagia, nausea or
vomiting, dyspnea
- (-) meds/ consult
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 6/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENTHx
OF
P
R
E
S
EN
T
I
LL
N
E
S
S
1 day PTA
- (+) persistence of productive
cough, whitish phlegm worse
at night
- (+) undocumented fever, dyspnea- (-) colds, headache, dysphagia, nausea
or vomiting
- (-) limitation of daily activity
(attended dance practice)- (+) Salbutamol Nebulization
Q4: provided temporary relief
- (-) consult
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 7/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENTHx
OF
P
R
E
S
EN
T
I
LL
N
E
S
S
Few hours PTA
- (+) persistence of symptoms with
anorexia & progressivedyspnea & chest tightness- (+) Consult with nearby clinic:
Combivent Neb. 1 dose no relief
- (+) Consult at DL-UMC ER:Persistent & progressive
dyspnea when W ALKING
- (+) Admitted
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 8/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENTP
A
ST
M
ED
I
C
AL
Hx
(+) Bronchial Asthma since 3
years old-Last Attack: November 2011
- Salbutamol Inhaler PRN
(+) Allergy : shrimp
(-) previous HOSPITALIZATION/
surgery, allergic rhinitis,atopy
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 9/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENTF
A
MI
L
Y
ME
D
I
CA
L
Hx
(+) Bronchial Asthma:maternal
(+) Allergic Rhinitis:
maternal
(+) Hypertension:
maternal
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 10/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENT
B
I
R
TH
&
M
A
T
E
R
N
A
L
Hx
Born term @ 37 weeks via LTCSdue to CPD
MOTHER: (+) regular prenatal
check-ups
(-) UTI or previous
infections during pregnancy
BW: 3 kg
(-) Maternal and neonatalcomplications
(-) Normal NEWBORN
SCREENING
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 11/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENT
D
E
V
EL
O
P
M
E
N
T
A
L
Hx
Gross Motor - Rolls over at 6 months
- Sits at 12 months
- Walks at 13 monthsFine Motor
- Scribbles at 4 years old
Language- Phrases at around 15 months
Personal and Social
- interactive play at 2 y/o
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 12/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENT
N
U
T
R
I
T
IO
N
A
L
Hx
Breastfed until 1 year old
Supplementary feeding at 8 months
old
Cerelac
Promil for a year, then shifted toProgress from 3 to 4 years old.
Good appetite with no food
preference
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 13/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENT
(+) BCG (+) 3 doses of Hep. B, DPT,
OPV
(+) MMR (+) Hib
(+) pneumococcal
No serious reactions
I
M
MU
N
I
ZA
T
I
O
N
Hx
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 14/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENT
Grade 3 student
Active member of Buddhist Church
Regularly attend dance practice and
perform during worship
Usual Diet: chips, meat, rice
Lives in a 2-storey( SUBDIVISION) with her
parents and a sibling.
MOTHER: 30 Y/O, HOUSEWIFE, NON-
SMOKER,
NON- ALCOHOLIC
BEVERAGE
DRINKER.
FATHER: 32 Y/O, EMPLOYEE, OCCASIONAL
SMOKER AND ALCOHOLIC BEVERAGE
DRINKER
P
E
R
SO
N
A
L
S
O
C
I
A
L
Hx
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 15/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENT
POSITIVEDyspnea
Fever, undoc.
weakness
Prod. Cough
Anorexia
chest tightness
ColdsChills
Abdominal pain
Body malaise
Loss of
cosciousness
R
E
V
I
E
W
OF
S
Y
S
T
E
M
S
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 16/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENT
I. GENERAL SURVEYPatient is awake, mesomorph, and in moderate
respiratory distress. Patient appeared her
chronological age of 8.
II. VITAL SIGNSBP: 110/70mmHg
RR: 36 cpm
HR: 140
TEMP: 36.8 C
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 17/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENT
EXAMINATION OF THE SKIN
(-) pallor
(-) jaundice(-) primary or secondary skin lesions
(+) good skin turgor
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 18/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENT
EXAMINATION OF THE HEENT
(+) Pink palpebral conjunctiva
(-) eye discharge or tearing(-) icteric sclera
(-) CLAD
(+) supraclavicular retractions
(+) alar flaring
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 19/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENT
EXAMINATION OF THE CHEST AND LUNGS
(+) symmetric chest expansion
(+) tachypneic
(+) tight airways per auscultation(+) equal lung sounds
(+) wheezes
(-) crackles
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 20/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENT
CARDIOVASCULARSYSTEM
(+) tachycardic,
regular rhythm.(-) murmur
ABDOMEN
(+) Flat and
symmetrical
(-) visible veins,
pulsations or peristalsis.
(+) Normoactive
bowel sounds(+) soft and non-
tender .
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 21/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENT
EXAMINATION OF THE EXTREMITIES
(+) Full & equal peripheral pulses
(-) cyanosis(-) edema
(-) deformities
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 22/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENT
NEUROLOGIC
- Awake, conscious, coherent, oriented
to 3 spheres, speaks in sentences,ambulant.
-Cranial Nerves: intact
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 23/72
SALIENT FEATURES
CLINICAL HISTORY
(+) productive cough, whitishphlegm, worse at night
(+) dyspnea ( shortness of breathwhen walking)
(+) undocumented fever (+) anorexia (+) chest tightness (+) dyspnea responded with anti-
asthma therapy (salbutamol
nebulization) (+) history of diagnosis of bronchialasthma
(+) family history of bronchialasthma
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 24/72
SALIENT FEATURES
PHYSICAL EXAMINATION
tachycardic ( 140 bpm) tachypneic ( 36 cpm) (+) alar flaring (+) supraclavicular
retractions (+) tight airways per auscultation
(+) wheezes
(-) cyanosis speaks in words and inmoderate respiratory distress
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 25/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENT
PRIMARY WORKINGIMPRESSION:
Bronchial Asthma,partly controlled, in
acute moderateexacerbation
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 26/72
BRONCHIAL ASTHMA:
Clinically - Widespread airway narrowingwhich changes in severity over short
periods of time, either spontaneously or
in response to treatment Physiologically - Bronchial
Hyperresponsiveness
Pathologically - Airway inflammation
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 27/72
BRONCHIAL ASTHMA:
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 28/72
BRONCHIAL ASTHMA:
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 29/72
BRONCHIAL ASTHMA:
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 30/72
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 31/72
DIFFERENTIAL DIAGNOSES:1. PNEUMONIA
RULE IN RULE OUT
-Dyspnea
-Productive cough
- undocumented
fever
- anorexia
-Tachypneic (36cpm)- (+) supraclavicular
retractions
-(-) crackles
- can not be totally ruledout
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 32/72
DIFFERENTIAL DIAGNOSES:1. bronchiolitis
RULE IN RULE OUT
-Dyspnea
-Productive cough
- anorexia
-Tachypneic (36cpm)
- (+) alar flaring
-(+) wheezes- (+) supraclavicular retractions
-Severe symptoms
usually evident in infants
(3-6mons.)
- (-) coryza, congestion,
pharyngitis, colds
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 33/72
DIFFERENTIAL DIAGNOSES:1. bronchitis
RULE IN RULE OUT
-Dyspnea
-Productive cough
- anorexia
-Tachypneic (36cpm)
- (+) alar flaring
-(+) wheezes- (+) supraclavicular retractions
-(-) increased sputum volume
- (-) clad, sore throat, runny
nose, headache, muscleaches, extreme fatigue
- smoking is the predominant
cause
- affects male> fem- chronic bronchitis affects
more adults> children
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 34/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENTM
A
N
A
G
E
M
E
N
T
AT
THE
E.R
SUPPORTIVE:
O2 SPOT CHECK: 86%-> 96%->99%O2 support via face mask @ 6LPM
IVF: D5 0.3 NaCl 500cc x 28-29gtts/min
(Mild in 8)
THERAPEUTICS:
Continuous Nebulization with Ipatropium
bromide + Salbutamol (Duavent) for 1hour
Hydrocortisone 100 mg IV
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 35/72
PHYSICAL
EXAMINATION
CLINICAL
HISTORY
CLINICAL
IMPRESSIONMANAGEMENTM
A
N
A
G
E
M
E
N
T
AT
THE
E.R
DIAGNOSTICS:
CBC PC
Chest Xray APL
Advised Admission
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 36/72
COURSE IN THE WARDS1. DAY 0-1
S> (+) D YSPNEA, shortness of breath, chesttightness
O> HR: 126 RR32 TEMP36.8 C
O2 SAT: 96%
(+) WHEEZES, (+) SUPRACLAVICULAR
RETRACTIONS
(-) PALLOR, (-) RETRACTIONS, (-)
CRACKLES, (-) MURMUR, (-) DECREASED
BREATH SOUNDS, (-) CYANOSIS
A> BRONCHIAL ASTHMA IN ACUTE MODERATE
EXACERBATION;
PNEUMONIA
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 37/72
COURSE IN THE WARDS1. DAY 0-1
P> IVF:D5
0.3 NACL
500 CC X 28-29GTTS/MIN (MILD IN 8 HOURS)
DIAGNOSTICS:
- CBCPC: hgb 160, hct 0.48, wbc16.8segmenters 0.86
lymph0.11
monocytes0.02
platelet542
- CXR-APL: NON-SPECIFIC
PNEUMONITIS
COURSE IN THE WARDS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 38/72
COURSE IN THE WARDS1. DAY 0-1
P> THERAPEUTICS:- Hydrocortisone 90 mg iv q6
- salbutamol neb, alternate with
ipatropium bromide+salbutamol neb.
Q4- cefuroxime 700 mg iv q8 anst
SUPPORTIVE:
- 02 via face mask @ 5-6lpm hooked to continuous pulse oximeter
monitored vs q1 with fmrr
diet: hypoallergenic
COURSE IN THE WARDS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 39/72
COURSE IN THE WARDS1. DAY 1-2
S> (+) D YSPNEA
O> HR: 124 RR28 TEMP37.5 C
O2 SAT: 99%
(+) WHEEZES
(-) PALLOR, (-) RETRACTIONS, (-)CRACKLES,
(-) MURMUR, (-) DECREASED BREATH
SOUNDS, (-) CYANOSIS
A> BRONCHIAL ASTHMA IN ACUTE MODERATE
EXACERBATION;
PNEUMONIA
COURSE IN THE WARDS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 40/72
COURSE IN THE WARDS1. DAY 1-2
P> IVF:D5
NM500CC X 17-18GTTS/MIN(FM)
THERAPEUTICS:
- Hydrocortisone 90 mg iv q6
- cefuroxime 700 mg iv q8 anst- ipatropium bromide+salbutamol
nebulization Q4
- discontinued salbutamolnebulization
COURSE IN THE WARDS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 41/72
COURSE IN THE WARDS1. DAY 1-2
P> SUPPORTIVE:- 02 shifted to nasal cannula @
2-3lpm
hooked to continuous pulse
oximeter Monitored vs q4 with fmrr
diet: small frequent feedings
with sap
COURSE IN THE WARDS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 42/72
COURSE IN THE WARDS1. DAY 2-3
S> (+) slight dyspneaO> HR: 108 RR25 TEMP36.2 C
O2 SAT: 96%
(-) PALLOR, (-) RETRACTIONS, (-) wheezes(-
)CRACKLES, (-) MURMUR, (-) DECREASEDBREATH SOUNDS, (-) CYANOSIS
A> BRONCHIAL ASTHMA IN ACUTE MODERATE
EXACERBATION;
PNEUMONIA
COURSE IN THE WARDS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 43/72
COURSE IN THE WARDS1. DAY 2-3
P> IVF:D5
NM500CC X 17-18GTTS/MIN(FM)
THERAPEUTICS:
- Hydrocortisone 90 mg iv q6
- cefuroxime 700 mg iv q8 anst- ipatropium bromide+salbutamol
nebulization Q4
- started salmeterol+fluticasone 1 puff bid
(gargled every after use)
COURSE IN THE WARDS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 44/72
COURSE IN THE WARDS1. DAY 2-3
P> SUPPORTIVE:- 02 support shifted to PRn basis
hooked to continuous pulse
oximeter
Monitored vs q4 with fmrr diet: small frequent feedings
with sap
COURSE IN THE WARDS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 45/72
COURSE IN THE WARDS1. DAY 3-4
S> Slight dyspnea, occasionalO> HR: 108 RR25 TEMP36.2 C
O2 SAT: 96%
(+) WHEEZES
(-) PALLOR, (-) RETRACTIONS, (-)CRACKLES,(-) MURMUR, (-) DECREASED BREATH
SOUNDS, (-) CYANOSIS
A> BRONCHIAL ASTHMA IN ACUTE MODERATE
EXACERBATION;
PNEUMONIA
COURSE IN THE WARDS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 46/72
COURSE IN THE WARDS1. DAY 3-4
P> IVF:D5
NM500CC X KVO
THERAPEUTICS:
- Hydrocortisone 90 mg iv q6
- cefuroxime 700 mg iv q8 anst
- ipatropium bromide+salbutamolnebulization Q4
- salmeterol+fluticasone 1 puff
bid (gargled every after use) SUPPORTIVE:
- discontiued 02 support & pulse
oximeter .
COURSE IN THE WARDS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 47/72
COURSE IN THE WARDS1. DAY 3-4
P> MAY GO HOME:- CEFUROXIME 250mg/5ml, 6ml BID
for 7 more days
- clarithromycin 250mg/5ml, 3ml
bid for 7 days- ipatropium bromide+salbutamol
nebulization q6
- salmeterol+fluticasone 25mg/125mg inhaler, 2 puffs bid
- prednisone syrup 10mg/5ml, 5ml
xbid for 3 days
CASE DISCUSSION
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 48/72
CASE DISCUSSION
BRONCHIAL ASTHMA
- A chronic inflammatory disease of the airways.
-REVERSIBLE AIRWAY OBSTRUCTION
(bronchoconstriction, mucus plugs & increased
inflammation), INCREASED BRONCHIAL REACTIVITY,
AIRWAY INFLAMMATION
-Asthma attacks are episodic, but airway inflammation is
chronically present
-300 million individuals affected worldwide; prevalence is
increasing especially in children
CASE DISCUSSION
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 49/72
CASE DISCUSSION
CONFIRM BRONCHIAL ASTHMA DIAGNOSIS
CASE DISCUSSION
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 50/72
CASE DISCUSSION
Measurements of lung function provide an
assessment of repairability, and variability of
airflow limitation, and help confirm the
diagnosis of asthma.
SPIROMETRY: An increase in FEV1 of >12%
and >200 ml after administration of a
bronchodilator (reversible airflow limitation
consistent with asthma)
CASE DISCUSSION
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 51/72
CASE DISCUSSION
PEAK EXPIRATORY FLOW
Measurements can be an important aid in
both diagnosis and monitoring of asthma
AN improvement of 60L/min (or > 20% of
the pre-bronchodilator PEF), after inhalationof a bronchodilator
CASE DISCUSSION
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 52/72
CASE DISCUSSION
STEPSMANAGEMENT FOR PATIENTS WITH BRONCHIAL ASTHMA
Advice avoidance to triggering factors:
Tobacco smoke
drug, food, additives
House dust mites and cockroahes
Animals with furOutdoor pollens and mold
Indoor mold
Exercise
Pharmacologic Therapy
CASE DISCUSSION
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 53/72
CASE DISCUSSION
BRONCHIAL ASTHMA
-CONTROLLER: taken daily to prevent
symptoms, improve lung function, and
prevent attacks. Inhaled glucocorticosteroids
Systemic glucocorticosteroids
Cromones
Methylxanthines Long-acting inhaled 2-agonists
Long-acting oral 2-agonists
Leukotriene modifiers
Anti-IgE
CASE DISCUSSION
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 54/72
CASE DISCUSSION
BRONCHIAL ASTHMA
-RELIEVER: Treats acute symptoms such as
wheezing, chest tightness, and cough
Rapid-acting inhaled 2-agonists
Systemic glucocorticosteroids
Anticholinergics
Methylxanthines
Short-acting oral 2-agonists
CASE DISCUSSION
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 55/72
CASE DISCUSSION
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 56/72
FF22++ MechanismMechanism of Actionof Action
o muco-ciliary clearence
q v ascular permeability
Inhibition of transmitter release from mastcells
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 57/72
FF22 AgonistsAgonists
Selectiv e (Terbutaline, Salbutamol) ± First line therapy ± Short onset of action (2-5 min)
± Long duration of action (3-6 h) ± Different routes of administration
Non selectiv e (epinephrine) ± Vasoconstricting agent ± Short duration of action ± Side effects
A ti h li iA ti h li i
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 58/72
AnticholinergicsAnticholinergicsMechanismMechanism of Actionof Action
Ach competitiv e inhibitors
muscarinic receptors antagonists
Bronchodilators
Inhibitors of the bronchoconstriction induced byirritant agents
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 59/72
CorticosteroidsCorticosteroids
q hospital admission if administered within the 1st hour
Equal benefit of orally and IV administration ± Rowe et al. Cochrane Database Syst Rev, 2000
Dose ranging from 30-400 mg methylprednisolone :
± Manser et al. Cochrane Database Syst Rev, 2000 Inhaled vs systemic corticosteroids: (Edmonds et al. Cochrane
Database Syst Rev. 2003) ± o PEFR and FEV1 as compared with placebo
± as effective as systemic corticosteroids ?
± Combination better than systemic route alone ?
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 60/72
MethylxanthinesMethylxanthines
No benefit from adding methylxanthines to F2+
More adv erse effects ± Parameswaran et al. Cochrane Database Syst Rev 2000
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 61/72
MgSOMgSO44
Inhalation: ± Improv ement in clinical score (Fischl), o PEFR, o PP
± Nannini LJJr. Am J Med 2000
± Mangat HS Eur Respir J 1998 o PEFR
IV: ± Boonyav orakul C. Respiratology 2000
Hospital admission = NS; score = NS ± Rowe BH. Ann Emerg Med 2000
q admission rate in sev ere asthma exacerbations
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 62/72
AntibioticsAntibiotics
Graham et al. Cochrane Database Syst Rev .2001 ± No benefit when comparing antibiotics to placebo
Indications: GOLD-guideline (Pauwels et al.Respir Care 2001)
± Worsening dyspnea and cough ± Increased sputum v olume and purulence
± Infiltrates on the chest X-ray
CONTROLLERS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 63/72
CONTROLLERS
CONTROLLERS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 64/72
CONTROLLERS
CONTROLLERS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 65/72
CONTROLLERS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 66/72
COMBINATION MEDICATIONS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 67/72
RELIEVERS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 68/72
RELIEVERS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 69/72
RELIEVERS
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 70/72
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 71/72
REFERENCES
GLOBAL INITIATIVE FOR ASTHMA (2011)
8/3/2019 pedia-BA
http://slidepdf.com/reader/full/pedia-ba 72/72
THANK YOU
GOD BLESS